Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05763628 · ClinicalTrials.gov registry record · NA
Performance Evaluation of Different Daily Disposable Multifocal Contact Lenses
A NA study, sponsored by CooperVision.
- Completed
- Registry status
- NA
- Development phase
- 59
- Enrollment target
NCT05763628: Completed NA study, sponsored by CooperVision.
NCT05763628 is a NA study that has completed, run by CooperVision. The registered enrollment target is 59 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05763628, a NA study, has completed, sponsored by CooperVision.
- COMPLETED
- Registry status
- NA
- Development phase
- 59 participants
- Enrollment target
Study Summary
The objective of the study was to compare the lens performance of two daily disposable multifocal contact lenses.
Primary Outcome
Subjective rating for ease of removal of the study lenses on a 0-100 scale, where 0=Very difficult and 100=Very easy. Collected once at the end of 2 weeks of wear.
Interventions
- DEVICE Control Lens (stenfilcon A)
- DEVICE Test Lens (senofilcon A)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2022-12-10 |
| Est. Completion | 2023-06-15 |
| Phase | NA |
What the finished NCT05763628 record still lists
NCT05763628 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 59 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Control Lens (stenfilcon A) is the first listed.
NCT05763628 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05763628 about?
NCT05763628 is a clinical study titled "Performance Evaluation of Different Daily Disposable Multifocal Contact Lenses". The objective of the study was to compare the lens performance of two daily disposable multifocal contact lenses.
What is the current status of trial NCT05763628?
This trial is currently completed. It is a NA study. The enrollment target is 59 participants. The study started on 2022-12-10. Estimated completion is 2023-06-15.
What interventions are being tested in trial NCT05763628?
The interventions under investigation include: Control Lens (stenfilcon A) (DEVICE), Test Lens (senofilcon A) (DEVICE).
Who is sponsoring clinical trial NCT05763628?
This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05763628's enrollment target sits among peer trials
59 1256th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03801083 · 59 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
- NCT04332367 · 59 participants · Phase 2
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
- NCT05489575 · 59 participants · NA
CPAP for the Treatment of Supine Hypertension
- NCT06721689 · 59 participants · Phase 1
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI